it has been used in trials studying the treatment and prevention of Venous Thromboembolism and Acute Coronary Syndrome. it is an orally active, tetrahydropyrimidin-2(1H)-one derivative and inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. it does not affect bleeding time. 
